Jiujiang He

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features.

T. He, Hongxing Liu, Hui Wang, 2020, Blood advances.

5 years of clinical DC-CIK/NK cells immunotherapy for acute myeloid leukemia - a summary.

Hong Wang, Ping Wu, Yang Zhang, 2020, Immunotherapy.

Safety and Efficacy of Humanized Versus Murinized CD19 and CD22 CAR T-Cell Cocktail Therapy for Refractory/Relapsed B-Cell Lymphoma

Wen-qian Li, P. Lu, Xian Zhang, 2022, Cells.

Long-term retrospective study of retinoic acid combined with arsenic and chemotherapy for acute promyelocytic leukemia

Wen-qian Li, P. Lu, Xian Zhang, 2022, International Journal of Hematology.

A Feasibility and Safety Study of a New CD19-Directed Fast CAR-T Therapy for Refractory and Relapsed B Cell Acute Lymphoblastic Leukemia

M. Zhang, Yongliang Zhang, Jiaping He, 2019, Blood.

Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia

Jiaping He, W. Cao, Wen-qian Li, 2019, Blood.